JARDIANCE® (empagliflozin) tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.

JARDIANCE® (empagliflozin) tablets are indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

What is the most important information I should know about JARDIANCE® (empagliflozin)
 

• Dehydration
• Ketoacidosis
• Urinary tract infections
• Genital tract infections

Who should not use JARDIANCE® (empagliflozin)
 

• Type 1 DM
• Patients with persistent eGFR<45 ml/min/1.73 m²

For more information, please see Prescribing Information